Paladin Labs sells 12.5 million shares of Isotechnika to ILJIN Life Science - MarketLine Financial Deals

Paladin Labs sells 12.5 million shares of Isotechnika to ILJIN Life Science

Paladin Labs sells 12.5 million shares of Isotechnika to ILJIN Life Science - MarketLine Financial Deals
Paladin Labs sells 12.5 million shares of Isotechnika to ILJIN Life Science
Published Feb 01, 2011
3 pages — Published Feb 01, 2011
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Paladin Labs, Inc., a pharmaceutical company, has sold 12.5 million common shares of Isotechnika Pharma, Inc. to ILJIN Life Science Co., Ltd., a Korea-based company engaged in the clinical and commercial development of voclosporin, for a consideration of CAD3.25 million ($3.25 million).

  
Source:
Document ID
MA38898_101118
Country
Country
Ticker
PLB=CA
Ticker
ISA=CA
Company
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Paladin Labs sells 12.5 million shares of Isotechnika to ILJIN Life Science" Feb 01, 2011. Alacra Store. Dec 03, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Paladin-Labs-sells-12-5-million-shares-of-Isotechnika-to-ILJIN-Life-Science-2052-47514>
  
APA:
MarketLine Financial Deals. (2011). Paladin Labs sells 12.5 million shares of Isotechnika to ILJIN Life Science Feb 01, 2011. New York, NY: Alacra Store. Retrieved Dec 03, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Paladin-Labs-sells-12-5-million-shares-of-Isotechnika-to-ILJIN-Life-Science-2052-47514>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.